Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma
Open Access
- 1 November 2018
- journal article
- research article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 33 (6), 1093-1102
- https://doi.org/10.3904/kjim.2016.412
Abstract
Background/Aims: The aim of this study was to investigate parameters that predict radiation-induced liver disease (RILD) following stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC) and to identify the clinical significance of RILD. Methods: We retrospectively reviewed the medical records of 117 HCC patients who were treated by SBRT from March 2011 to February 2015. RILD was defined as elevated liver transaminases more than five times the upper normal limit or a worsening of Child-Pugh (CP) score by 2 within 3 months after SBRT. All patients were assessed at i month and every 3 months after SBRT. Results: Median follow-up was 22.5 months (range, 3 to 56) after SBRT. RILD was developed in 29 of the ir patients (24.7%). On univariate analysis, significant predictive factors of RILD were pretreatment CP score (p < o.00i) and normal liver volume (p = o.002). Multivariate analysis showed that CP score was a significant predictor of RILD (p < o.00i). The incidence of RILD increased above a CP score of 6 remarkably. The rate of recovery from RILD decreased significantly above a CP score of 8. Survival analysis showed that CP score was an independent prognostic factor of overall survival (p = o.00i). Conclusions: CP score is a significant factor to predict RILD in patients with chronic liver disease. RILD can be tolerated by patients with a CP score s 7. However, careful monitoring of liver function is needed for patients with a CP score 7 after SBRT.Keywords
This publication has 29 references indexed in Scilit:
- Predictors of Toxicity Associated With Stereotactic Body Radiation Therapy to the Central Hepatobiliary TractInternational Journal of Radiation Oncology*Biology*Physics, 2015
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular CarcinomaPLOS ONE, 2013
- Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parametersRadiation Oncology, 2013
- Report of the 18th follow‐up survey of primary liver cancer in JapanHepatology Research, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation toleranceInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Analysis of radiation-induced liver disease using the Lyman NTCP modelInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Hepatic toxicity resulting from cancer treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard modelCancer, 1991
- Small hepatocellular carcinoma: intratumor ethanol treatment using new needle and guidance systems.Radiology, 1987